V-erbA-related gene

Source: Wikipedia, the free encyclopedia.
NR2F6
Identifiers
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_005234

NM_010150

RefSeq (protein)

NP_005225
NP_005225.2

NP_034280

Location (UCSC)Chr 19: 17.23 – 17.25 MbChr 8: 71.83 – 71.83 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

V-erbA-related protein 2 (EAR-2) also known as NR2F6 (nuclear receptor subfamily 2 group F member 6) is a

intracellular transcription factors. It is named after its similarity to v-erbA (P03373), a helper of an oncoprotein called v-erbB in avian erythroblastosis virus.[6]

Function

Comparatively little is known about ear-2, but it has been shown to function as a coregulator of other nuclear receptors.[7][8]

Nr2f6

locus ceruleus.[9]

It was found that antigen receptor stimulation-induced NF-AT/AP-1 activity is regulated through the nuclear receptor NR2F6 (NR2F6 acts as a direct repressor of NF-AT/AP-1 transactivation) and that by preventing NR2F6 function, transcriptional activation of NF-AT/AP-1 is enhanced in immune cells which leads to an augmented immune response.[10]

NR2F6 impairs the formation of mature red blood cells in animals that over-express NR2F6 in their bone marrow. Mice that over expression of NR2F6 in their bone marrow cells have a block at the pro-erythroblast stage of blood cell development both in the bone marrow and in the spleen of animals that have excessive expression of NR2F6. So, when inhibition of differentiation of stem cell is desired, inhibition of differentiation is achieved through induction of increased NR2F6 activity. In situations where differentiation of stem cells into a cell of increased maturity is desired, inhibition of NR2F6 activity must be performed.[11]

Clinical significance

It was found that expression of NR2F6 was consistently upregulated in neoplastic tissues in leukemic, ovarian cancer and endometrial cancer as compared to non-malignant tissues, while the silencing of NR2F6 induces a reduction of cancer cell proliferation, inhibiting clonogenicity and self-renewal of proliferating cancer cells, and induces differentiation.[12]

Interactions

V-erbA-related gene has been shown to

interact
with:

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000160113Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000002393Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. PMID 2905047
    .
  6. .
  7. ^ .
  8. .
  9. .
  10. ^ Baier, G. and Hermann-Kleiter, N., Medizinische Universitat Innsbruck, (2011). Antagonists of NR2F6 For Augmenting The Immune Response. U.S. Patent Application 13/004,781.
  11. ^ Ichim, C.V. and Ichim, T., (2015). Modulation of Hematopoietic Stem Cell Differentiation. U.S. Patent 20,150,299,712.
  12. ^ Ichim, C. V. (2015). Methods and Compositions for treatment of cancer by inhibition of NR2F6 U.S. Patent No. 20,150,291,964. Washington, DC: U.S. Patent and Trademark Office.
  13. PMID 10318855
    .

Further reading

External links